[Cyclosporine A improves the nuclear entry of hepatitis B virus core protein in HepG2.2.15 cells]

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007 Dec;21(4):310-2.
[Article in Chinese]

Abstract

Objective: The present aimed to observe the effect of phosphatase inhibitor cyclosporine A on the subcellular location and on expression of HBcAg in HepG2.2.15 cells.

Methods: Thirty micrograms/ml of cyclosporine A (CSA) was added into HepG2.2.15 cell culture system and on days 2 and 4 HBcAg and HBsAg were respectively stained with fluorescent immunocytochemistry and observed under confocal microscope. Cell apoptosis was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling method.

Results: HBcAg was mostly expressed in cytoplasm in the control HepG2.2.15 cells. After 2 days CSA administration of the expression of HBcAg and HBsAg in cytoplasm significantly decreased and the signals of HBcAg in nucleus increased , whereas the HBcAg was still mainly expressed in nucleus in about 1/4 of the cells. Cell apoptosis was observed in about 30% of the cells.

Conclusion: CSA improves the nuclear entry of core protein. The increase of HBcAg in nucleus was likely to be related with it's phosphorylation and cell aging or apoptosis.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus
  • Apoptosis
  • Cell Line, Tumor
  • Cell Nucleus / metabolism*
  • Cyclosporine / pharmacology*
  • Cytoplasm / metabolism
  • Hepatitis B Core Antigens / analysis
  • Hepatitis B Core Antigens / metabolism*
  • Hepatitis B Surface Antigens / analysis
  • Humans
  • In Situ Nick-End Labeling
  • Phosphorylation

Substances

  • Hepatitis B Core Antigens
  • Hepatitis B Surface Antigens
  • Cyclosporine